Pharmacologic management of pediatric asthma

Immunology and Allergy Clinics of North America

Volumn 18, Issue 1, 1998, Pages 165-181

  Spahn, J D ^a   Szefler, S J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; IMMUNOMODULATING AGENT; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; NEDOCROMIL SODIUM; PHOSPHODIESTERASE INHIBITOR; PIRBUTEROL ACETATE; PREDNISONE; SALBUTAMOL; SALMETEROL XINAFOATE; STEROID; TERBUTALINE SULFATE; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST; ZILEUTON;

ADRENAL SUPPRESSION; AIR POLLUTION; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; DERMATOPHAGOIDES PTERONYSSINUS; DRUG DELIVERY SYSTEM; DRUG USE; DYSPHONIA; GROWTH INHIBITION; HIRSUTISM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METERED DOSE INHALER; MYOPATHY; OBESITY; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATIENT EDUCATION; PEAK EXPIRATORY FLOW; POVERTY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SIDE EFFECT; SKIN DISEASE; SUSTAINED RELEASE PREPARATION; THRUSH; URBANIZATION;

EID: 0031933078     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70354-4     Document Type: Article

References (67)

1. L. Agertoft S. Pedersen Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children Respir Med 88 1994 373 381
2. P.J. Barnes Cyclic nucleotides and phosphodiesterases in airway function Eur Respir J 8 1995 457 462
3. P.J. Barnes Immunomodulation as asthma therapy: Where do we stand? Eur Respir J 9 1996 154s 159s
4. P.J. Barnes S. Pedersen Efficacy and safety of inhaled corticosteroids in asthma Am Rev Respir Dis 148 1993 S1 S26
5. P.G.M. Bloemen P.A.J. Henricks F.P. Nilkamp Cell adhesion molecules in asthma Clin Exper Allergy 27 1997 128 141
6. M. Boguniewicz L.C. Schneider H. Milgrom Treatment of steroid dependent asthma with recombinant interferon-gamma J Allergy Clin Immunol 89 1992 288
7. M. Boorsma N. Andersson P. Larsson Assessment of relative systemic potency of inhaled fluticasone and budesonide Eur Respir J 9 1996 1427 1432
8. L. Borish L. Rosenwasser TH1/TH2 lymphocytes: Doubt some more (editorial) J Allergy Clin Immunol 99 1997 161 164
9. S.L. Bowyer M.P. LaMothe J.R. Hollister Steroid myopathy: incidence and detection in a population with asthma J Allergy Clin Immunol 76 1985 234 242
10. G. Boyd S. Abdallah R. Clark Twice or four times daily beclomethasone dipropionate in mild stable asthma? Clin Allergy 15 1985 383 389
11. M. Brenner R. Berkowitz N. Marshall Need for theophylline in severe steroid-requiring asthmatics Clin Allergy 18 1988 143 150
12. S. Cameron E.T. Cooper G.K. Crompton Substitution of beclomethasone aerosol for oral prednisolone in the treatment of chronic asthma Br Med J 4 1973 205 207
13. K.F. Chung Leukotriene receptor antagonists and biosynthesis inhibitors: Potential breakthrough in asthma therapy Eur Respir J 8 1995 1203 1213
14. D.J. Clark A. Grove R.I. Cargill Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients Thorax 51 1996 262 266
15. J.A. Coutts N.A. Gibson J.Y. Paton Measuring compliance with inhaled medication in asthma Arch Dis Child 67 1992 332 333
16. R. Dahl B. Pedersen Influence of nedocromil sodium on the dual asthmatic reaction after antigen challenge: a double blind, placebo controlled study Eur J Respir Dis 69 1986 263 267
17. J.A. Douglas D.V. Tuxen M. Horne Myopathy in severe asthma Am Rev Respir Dis 146 1992 517 519
18. J.M. Drazen E. Isreal H.A. Boushey Comparison of regularly scheduled with as-needed use of albuterol in mild asthma N Engl J Med 335 1996 841 847
19. Expert Panel Report II Guidelines for the Diagnosis and Management of Asthma. Publication No. 97–405 1997 National Institutes of Health, National Heart, Lung, and Blood Institute Bethesda, MD
20. 2 agonist Br Med J 301 1990 1365 1368
21. P.J. Gergen K.B. Weiss Changing patterns of asthma hospitalization among children: 1979–1987 JAMA 264 1990 1688 1692
22. R.W. Gotlin Endocrine and metabolic disorders G.B. Merenstein D.W. Kaplan A.A. Rosenberg Handbook of Pediatrics ed 17 1994 Appleton & Lange Norwalk, CT 743 779
23. C.P. Green J.F. Price Prevention of exercise induced asthma by inhaled salmeterol xinafoate Arch Dis Child 67 1992 1014 1017
24. N.J. Gross Ipratropium bromide N Engl J Med 319 1988 486 494
25. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma N Engl J Med 325 1991 388 392
26. T. Haahtela M. Jarvinen T. Kava Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma N Engl J Med 331 1994 700 705
27. J.B. Harris M.M. Weinberger E. Nassif Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators J Pediatr 110 1987 627 633
28. J.G. Harter W.J. Reddy G.W. Thorn Studies on an intermittent corticosteroid dosage regimen N Engl J Med 269 1963 591 596
29. R.G. Hegele J.C. Hogg The pathology of asthma: An inflammatory disorder S.J. Szefler D.Y.M. Leung Severe Asthma: Pathogenesis and Clinical Management 1995 Marcel Dekker New York 61 76
30. L. Hendeles M. Weinberger S.J. Szefler Safety and efficacy of theophylline in children with asthma J Pediatr 120 1992 177 183
31. J.C.M. Hoekx G. Hedlin W. Pedersen Fluticasone propionate compared with budesonide: A double-blind trial in asthmatic children using powder devices at a dosage of 400 mcg/day Eur Respir J 9 1996 2263 2272
32. E. Isreal P. Rubin J.P. Kemp The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma Ann Intern Med 119 1993 1059 1066
33. A.K. Kamada D.Y.M. Leung M.C. Gleason High-dose systemic glucocorticoid therapy in the treatment of severe asthma: A case of resistance and patterns of response J Allergy Clin Immunol 90 1992 685 687
34. G.L. Larsen Asthma in children N Engl J Med 326 1992 1540 1545
35. M.C. Liu L.M. Dube J. Lancaster Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial J Allergy Clin Immunol 98 1996 859 871
36. B.P. Lukert L.G. Raisz Glucocorticoid-induced osteoporosis: pathogenesis and management Ann Intern Med 112 1990 352 364
37. J.L. Malo A. Cartier N. Merland Four-times-a-day dosing frequency is better than twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma Am Rev Respir Dis 140 1989 624 628
38. E.O. Meltzer J.P. Kemp M.J. Welch Effect of dosing schedule on efficacy of beclomethasone dipropionate aerosol in chronic asthma Am Rev Respir Dis 131 1985 732 736
39. H. Milgrom B. Bender L. Ackerson Noncompliance and treatment failure in children with asthma J Allergy Clin Immunol 98 1996 1051 1057
40. A. Muittari K.E. Kreus Disodium cromoglycate in exercise-induced asthma Br J Med 4 1969 170
41. H.S. Nelson Beta-adrenergic bronchodilators N Engl J Med 333 1995 499 506
42. M. Noonan P. Chervinsky W.W. Busse Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life Am J Respir Crit Care Med 152 1995 1467 1473
43. D. Ratto C. Alfaro J. Sipsey Are intravenous corticosteroids required in status asthmaticus? JAMA 260 1988 527 529
44. L.G. Reimer H.G. Morris E.F. Ellis Growth of asthmatic children during treatment with alternate-day steroids J Allergy Clin Immunol 55 1975 224 231
45. S.A. Rivkees M. Danon J. Herrin Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure J Pediatr 125 1994 322 325
46. G. Russell Asthma and Growth Arch Dis Child 69 1993 695 698
47. R.J. Scarfone S.M. Fuchs A.L. Nager Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma Pediatrics 92 1993 513 518
48. S. Schuh D.W. Johnson S. Callahan Efficacy of frequent nebulized ipratropium bromide added to frequent high dose albuterol in the treatment of severe childhood asthma J Pediatr 126 1995 639 645
49. M.R. Sears D.R. Taylor C.G. Print Regular inhaled beta-agonist treatment in bronchial asthma Lancet 336 1990 1391 1396
50. R.L. Shields W.R. Whether K. Zioncheck Inhibition of allergic reactions with antibodies to IgE Int Arch Allergy Immunol 107 1995 308 312
51. R.M. Sly R. O'Donnell Stabilization of asthma mortality Ann Allergy Asthma Immunol 78 1997 347 354
52. J.D. Spahn D.Y.M. Leung The role of glucocorticoids in the management of asthma Allergy Asthma Proc 17 1996 341 350
53. J.D. Spahn S.J. Szefler The etiology and control of bronchial hyperresponsiveness in children Curr Opin Pediatr 8 1996 591 596
54. S.L. Spector L.J. Smith M. Glass Effects of 6 weeks of therapy with ICI 204, 219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma Am J Respir Crit Care Med 150 1994 618 623
55. W.O. Spitzer S. Suissa R.I. Horowitz The use of beta-agonists and the risk of death and near death from asthma N Engl J Med 326 1992 501 506
56. R.E. Strauss D.L. Wertheim V.R. Bonagura Aminophylline therapy does not improve outcome and increase adverse effects in children hospitalized with acute asthmatic exacerbations Pediatrics 93 1994 205 210
57. S.J. Szefler Glucocorticoid therapy for asthma: clinical pharmacology J Allergy Clin Immunol 88 1991 147 164
58. S.M. Tarlo I. Broder G.M. Davies Six-month double-blind, controlled trial of high dose, concentrated beclomethasone dipropionate in the treatment of severe asthma Chest 93 1988 998 1002
59. J.H. Toogood Complications of topical steroid therapy for asthma Am Rev Respir Dis 141 1990 S89 S96
60. J.H. Toogood B. Jennings J. Baskerville Clinical use of spacer systems for corticosteroid inhalation therapy: A preliminary analysis Eur J Respir Dis 63 1982 100 107
61. E.E. Van Essen-Zandvliet M.D. Hughes J. Herman Effects of 22 months of treatment with inhaled corticosteroids and/or beta-agonists on lung function, airway responsiveness, and symptoms in children with asthma Am Rev Respir Dis 146 1992 547 554
62. J. Webb T.J.H. Clark C. Chilvers Time course of response to prednisolone in chronic airflow obstruction Thorax 36 1981 18 21
63. M. Weinberger The value of theophylline for asthma Ann Allergy 63 1989 1 3
64. S.E. Wenzel Asthma as an inflammatory disease Ann Allergy 72 1994 261 271
65. A.M. Whelan N.W. Hahn Optimizing drug delivery from metered dose inhalers DICP, Ann Pharmacother 25 1991 638 645
66. A. Woolcock B. Lundback N. Ringdal Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids Am J Respir Crit Care Med 153 1996 1481 1488
67. R.E. Younger P.S. Gerber H.G. Herrod Intravenous methylprednisolone efficacy in status asthmaticus of childhood Pediatrics 80 1987 225 230